8 Home Healthcare and Remote Visit Companies for Clinical Trials in 2026

A remote patient visit provider brings a clinical trial visit to the patient instead of requiring the patient to travel to a site, using mobile nurses, phlebotomists, and other healthcare professionals to complete assessments, sample collection, or monitoring in a patient's home. This kind of home healthcare clinical trials provider ranges from companies purpose-built for decentralized trial delivery to broader home-nursing networks originally built for general healthcare that sponsors can draw on for study visits when a dedicated clinical trial home-visit vendor isn't available in a given market.

The companies below are listed in no particular order. Between them, these companies and providers cover dedicated clinical trial home-visit networks, remote patient monitoring platforms, patient travel and logistics support, and large general home-nursing or portable diagnostic networks that can extend into clinical trial support.

CliniQnect

CliniQnect brings clinical trial site visits directly to patients' homes, workplaces, or schools through a network of mobile nurses, phlebotomists, and other healthcare professionals operating in more than 60 countries across Europe and Asia. The company, part of the First Wellness Testing Group, built its home-visit expertise through prior work developing global doping-control programs for the sports industry, giving it experience coordinating decentralized sample collection at scale before applying that model to clinical trials. CliniQnect positions itself as a turnkey partner, assigning a dedicated project management team to handle coordination, technical support for medical devices, remote patient monitoring, and full logistics for decentralized trial activities rather than leaving sponsors to manage multiple separate vendors. The company also offers emergency unblinding services and self-sampling and at-home microsampling solutions as part of its broader home trial support offering.

Current Health

Current Health provides a remote patient monitoring platform built around an FDA-cleared wearable biosensor, clinical dashboards, and integrated telehealth, letting healthcare organizations and pharmaceutical sponsors track patient vital signs at home and coordinate video visits without requiring in-person site attendance. Founded in 2014 by Christopher McCann in Edinburgh, with a second base in Boston, the company was acquired by Best Buy for roughly $400 million in 2021, before Best Buy divested the business back to its founder in June 2025, making it an independent company again. Current Health has worked with pharmaceutical partners including AstraZeneca and Amgen to administer drug trials at home, and with research institutions including the Mayo Clinic on decentralized clinical trial programs, alongside health system partnerships supporting hospital-at-home and oncology-at-home care. The company reports its platform has supported more than 70,000 patients across its combined healthcare and clinical research work.

Lightship

Lightship delivers clinical trial visits to patients wherever they are, combining traditional in-clinic appointments with at-home nursing visits, virtual check-ins, and mobile research units, an approach the company says has more than doubled participant enrollment compared with relying on brick-and-mortar sites alone. Founded in 2018 and based in El Segundo, California, the company expanded its combined footprint through a 2025 merger with Circuit Clinical and a February 2026 acquisition of Veda Trials, adding specialty clinics for women's health, dermatology, and allergy and asthma to its network. Lightship reports that more than 40 percent of the patients it reaches through its expanded delivery model come from racially or ethnically diverse communities that traditional site-based recruitment often struggles to include. The company positions its coordinated, single-team model as removing the friction of managing separate vendors for site visits, home visits, and virtual care across a single study.

MDGroup

MDGroup supports clinical trial participation across the full patient journey, offering in-home clinical procedures and assessments alongside personalized travel, accommodation, relocation, and reimbursement services for patients who do need to travel to a site. The company reports a 99 percent patient satisfaction rate across its work and positions its dedicated patient navigators as providing 24/7 human-led, multilingual support that helps patients stay informed and engaged rather than treating logistics as a purely transactional service. MDGroup structures its offerings around specific trial delivery models, including fully decentralized studies where in-home procedures replace most site visits, and hybrid studies that balance in-home visits with occasional travel for essential site-based assessments. The company cites industry data showing that patient-focused trials recruit roughly twice as many participants in nearly half the time of less patient-centered approaches, and that products tested this way are 19 percent more likely to reach launch.

Medicalib

Medicalib operates a geolocation-based platform connecting patients with independent nurses, physiotherapists, and midwives for in-home care visits across France, typically confirming an appointment in under an hour through a network the company says has grown to more than 25,000 registered healthcare professionals. Founded in 2017 and based in Paris, the company has processed more than 220,000 care requests to date and received investment and strategic support from Korian, a major operator of care facilities, to help develop a smart assistant tool for its home care professionals. Medicalib's free-to-patient model is funded on the professional side, and the platform integrates with France's national health data systems, including Mon Espace Santé, for compliant data handling. While Medicalib's core business serves general home healthcare demand rather than clinical trials exclusively, its national nursing and allied-health network represents the kind of home-visit infrastructure clinical trial sponsors can draw on for decentralized study visits in France.

6. PrivatAssistenza

PrivatAssistenza has operated as a division of ItaliAssistenza S.p.A since 1993, when it launched in Reggio Emilia as one of Italy's first professional home care assistance services, and has since grown into the country's largest national home care network with more than 180 operating centers reaching over 2,000 municipalities. The company's roughly 4,000 qualified operators serve more than 40,000 families annually with tailored home nursing, physiotherapy, hospital support, and caregiver replacement services delivered around the clock. Like several other large home care networks, PrivatAssistenza's core client base is general elder and disability care rather than clinical trials specifically, though its extensive, quality-accredited nursing footprint represents the kind of home-visit infrastructure sponsors running decentralized trials in Italy could draw on for patient visits outside traditional site settings. The company has also begun incorporating telemedicine into its service model, letting elderly and homebound patients receive specialist consultations remotely rather than traveling to a hospital.

TridentCare

TridentCare delivers bedside digital X-ray, ultrasound, EKG, and clinical laboratory services directly to patients in skilled nursing facilities, private residences, and other non-hospital settings, operating in 43 states as what it describes as the national leader in portable diagnostic services. The company's current form traces to a 2016 merger between TridentUSA and Schryver Medical, the country's second-largest portable diagnostics provider at the time, a deal that added respiratory therapy services to the combined company's offerings. TridentCare's imaging is reviewed by board-certified radiologists through its teleradiology partner, and its lab network holds CLIA certification along with CAP and COLA accreditations, giving its diagnostic results a level of regulatory backing suited to clinical use. While TridentCare's core business serves post-acute and long-term care settings broadly rather than clinical trials specifically, its scale and diagnostic breadth position it as infrastructure sponsors could draw on for at-home diagnostic support in decentralized study designs.

Tryal

Tryal builds an AI-powered eClinical platform that combines eCOA, eConsent, eSource, EDC, televisit, and Home Healthcare Administration modules into a single system, aiming to compress the time between finalizing a study protocol and deploying working clinical technology. Based in Austin, Texas, the company added an enhanced eConsent module in 2023 that lets participants review consent materials remotely and finalize them on-site if they choose, alongside built-in televisit scheduling so participants can quickly reach site staff with questions outside clinic hours. Tryal's Home Healthcare Administration module is built to coordinate and track in-home visits as part of the same platform used for data capture and consent, rather than requiring a separate system for remote visit logistics. The company has presented its AI-driven approach to eClinical deployment at industry events including the CNS Summit, positioning intelligent automation as a way to reduce the time and resources typically required to build and launch new trial technology.

Explore the full Patient Remote Visits landscape

The companies above represent a portion of a much larger field.

Diligent's platform includes over 180 Patient Remote Visits Vendors, with Vendor qualification data available on demand. Book a demo to explore Diligent's full vendor discovery database.

This article is intended as an informational overview of vendors operating in this space. Inclusion on this list does not constitute an endorsement, recommendation, or qualification by Diligent.